Podcast #5: Doing Digital Deals in Life Sciences | Deal Structure, Terms, and Series Conclusions
Welcome to the fifth and final episode in our podcast series “Digital Deals in Life Sciences – What Makes Them…
Welcome to the fifth and final episode in our podcast series “Digital Deals in Life Sciences – What Makes Them…
A vast range of specialty commercial drug products require temperature-controlled distribution and storage to ensure quality, safety, and efficacy. Some of…
Biomanufacturing has had an interesting couple of years. Unprecedented spikes in demand from the global COVID-19 pandemic have been followed…
Welcome to the fourth of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them…
Welcome to the third of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them…
How do top business decision makers regard the brands shaping the world’s biggest industries? GlobalData is conducting a comprehensive survey…
A GlobalData conducted in 2023 found that, according to 100 healthcare industry professionals, genomics was regarded as the most potentially…
The pharmaceutical industry faces myriad challenges affecting its supply chain, from stringent regulatory requirements to the urgent need for agility…
Welcome to the second of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them…
How can pharmaceutical firms optimise their operations? In an industry characterised by constant flux, it is a question that logistics…